Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 1/2014

01.09.2014 | Case Report

Isolated Severe Immune Thrombocytopenia due to Acute Brucellosis

verfasst von: Ozlem Guzel Tunccan, Murat Dizbay, Esin Senol, Zeynep Aki, Kevser Ozdemir

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Sonderheft 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Mild anemia and leukopenia are the most common hematologic findings in the course of acute brucellosis. However severe form of thrombocytopenia is less frequently reported. The patient was admitted to the hospital with fever, gingival bleeding, and petechial skin lesions related to severe thrombocytopenia. He was investigated for the causes of thrombocytopenia. Test results showed that Wright agglutination test was positive at 1/5120 titer, and blood culture was positive for Brucella melitensis. Finally, he was diagnosed as acute brucellosis. Rifampicin and doxycycline treatment was started on he third day of admission. A bone marrow aspiration was performed on the seventh day of admission because of severe thrombocytopenia did not response to brucellosis treatment. The result of bone marrow aspiration was consistent with idiopathic thrombocytopenic purpura. With the addition of corticosteroid treatment, his complaints resolved immediately, and thrombocyte count rose to normal range. He was discharged on the 12th day of rifampicin and doxycycline therapy, and he was successfully completed 6-week therapy. In cases of brucella induced immune thrombocytopenia, corticosteroid treatment might be useful for the prevention of bleeding complications.
Literatur
1.
Zurück zum Zitat Buzgan T, Karahocagil MK, Irmak H, Baran AI, Karsen H, Evirgen O, Akdeniz H (2010) Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int J Infect Dis 14(6):e469–e478PubMedCrossRef Buzgan T, Karahocagil MK, Irmak H, Baran AI, Karsen H, Evirgen O, Akdeniz H (2010) Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int J Infect Dis 14(6):e469–e478PubMedCrossRef
2.
Zurück zum Zitat Sari I, Altuntas F, Hacioglu S, Kocyigit I, Sevinc A, Sacar S, Deniz K, Alp E, Eser B, Yildiz O, Kaynar L, Unal A, Cetin MA (2008) Multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis. Am J Hematol 83(4):334–339PubMedCrossRef Sari I, Altuntas F, Hacioglu S, Kocyigit I, Sevinc A, Sacar S, Deniz K, Alp E, Eser B, Yildiz O, Kaynar L, Unal A, Cetin MA (2008) Multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis. Am J Hematol 83(4):334–339PubMedCrossRef
3.
Zurück zum Zitat Akdeniz H, Irmak H, Seçkinli T, Buzgan T, Demiröz AP (1998) Hematological manifestations in brucellosis cases in Turkey. Acta Med Okayama 52(1):63–65PubMed Akdeniz H, Irmak H, Seçkinli T, Buzgan T, Demiröz AP (1998) Hematological manifestations in brucellosis cases in Turkey. Acta Med Okayama 52(1):63–65PubMed
4.
Zurück zum Zitat Madkour MM (2001) Haematological localisation. In: Madkour MM (ed) Madkour’s Brucellosis. Springer, Germany, pp 33–38CrossRef Madkour MM (2001) Haematological localisation. In: Madkour MM (ed) Madkour’s Brucellosis. Springer, Germany, pp 33–38CrossRef
5.
Zurück zum Zitat Pappas G, Kitsanou M, Christou L, Tsianos E (2004) Immune thrombocytopenia attributed to brucellosis and other mechanisms of Brucella-induced thrombocytopenia. Am J Hematol 5(3):139–141CrossRef Pappas G, Kitsanou M, Christou L, Tsianos E (2004) Immune thrombocytopenia attributed to brucellosis and other mechanisms of Brucella-induced thrombocytopenia. Am J Hematol 5(3):139–141CrossRef
6.
Zurück zum Zitat Yilmaz M, Tiryaki O, Namiduru M, Okan V, Oguz A, Buyukhatipoglu H, Karaoglan I, Yilmaz B (2007) Brucellosis-induced immune thrombocytopenia mimicking ITP: a report of seven cases. Int J Lab Hematol 29(6):442–445PubMedCrossRef Yilmaz M, Tiryaki O, Namiduru M, Okan V, Oguz A, Buyukhatipoglu H, Karaoglan I, Yilmaz B (2007) Brucellosis-induced immune thrombocytopenia mimicking ITP: a report of seven cases. Int J Lab Hematol 29(6):442–445PubMedCrossRef
7.
Zurück zum Zitat Young EJ, Tarry A, Genta RM, Ayden N, Gotuzzo E (2000) Thrombocytopenic purpura associated with brucellosis: report of 2 cases and literature review. Clin Infect Dis 31(4):904–909PubMedCrossRef Young EJ, Tarry A, Genta RM, Ayden N, Gotuzzo E (2000) Thrombocytopenic purpura associated with brucellosis: report of 2 cases and literature review. Clin Infect Dis 31(4):904–909PubMedCrossRef
8.
Zurück zum Zitat Akbayram S, Dogan M, Akgun C, Peker E, Parlak M, Oner AF (2011) Disseminated intravascular coagulation in a case of Brucellosis. Clin Appl Thromb Hemost 17(6):E10–E12PubMedCrossRef Akbayram S, Dogan M, Akgun C, Peker E, Parlak M, Oner AF (2011) Disseminated intravascular coagulation in a case of Brucellosis. Clin Appl Thromb Hemost 17(6):E10–E12PubMedCrossRef
9.
Zurück zum Zitat Erduran E, Makuloglu M, Mutlu M (2010) A rare hematological manifestation of brucellosis: reactive hemophagocytic syndrome. J Microbiol Immunol Infect 43(2):159–162PubMedCrossRef Erduran E, Makuloglu M, Mutlu M (2010) A rare hematological manifestation of brucellosis: reactive hemophagocytic syndrome. J Microbiol Immunol Infect 43(2):159–162PubMedCrossRef
10.
Zurück zum Zitat Sari I, Kocyigit I, Altuntas F, Kaynar L, Eser B (2008) An unusual case of acute brucellosis presenting with Coombs-positive autoimmune hemolytic anemia. Intern Med 47(11):1043–1045PubMedCrossRef Sari I, Kocyigit I, Altuntas F, Kaynar L, Eser B (2008) An unusual case of acute brucellosis presenting with Coombs-positive autoimmune hemolytic anemia. Intern Med 47(11):1043–1045PubMedCrossRef
11.
Zurück zum Zitat Altuntas F, Yildiz O, Sari I, Eser B, Cetin M, Unal A (2005) Intravenous gamma globulin is effective as an urgent treatment in Brucella-induced severe thrombocytopenic purpura. Am J Hematol 80(3):204–206PubMedCrossRef Altuntas F, Yildiz O, Sari I, Eser B, Cetin M, Unal A (2005) Intravenous gamma globulin is effective as an urgent treatment in Brucella-induced severe thrombocytopenic purpura. Am J Hematol 80(3):204–206PubMedCrossRef
12.
Zurück zum Zitat Gürsoy B, Tekin-Koruk S, Sırmatel F, Karaağaç L (2008) Brucellosis. An evaluation of 140 cases. Klimik Derg 21(3):101–104 Gürsoy B, Tekin-Koruk S, Sırmatel F, Karaağaç L (2008) Brucellosis. An evaluation of 140 cases. Klimik Derg 21(3):101–104
13.
Zurück zum Zitat Colmenero JD, Reguera JM, Martos F, Sánchez-De-Mora D, Delgado M, Causse M, Martín-Farfán A, Juárez C (1996) Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore) 75(4):195–211CrossRef Colmenero JD, Reguera JM, Martos F, Sánchez-De-Mora D, Delgado M, Causse M, Martín-Farfán A, Juárez C (1996) Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore) 75(4):195–211CrossRef
14.
Zurück zum Zitat Mantur BG, Amarnath SK, Shinde RS (2007) Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol 25(3):188–202PubMedCrossRef Mantur BG, Amarnath SK, Shinde RS (2007) Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol 25(3):188–202PubMedCrossRef
15.
Zurück zum Zitat Sevinc A, Kutlu NO, Kuku I, Ozgen U, Aydogdu I, Soylu H (2000) Severe epistaxis in brucellosis-induced isolated thrombocytopenia: a report of two cases. Clin Lab Haematol 22(6):373–375PubMedCrossRef Sevinc A, Kutlu NO, Kuku I, Ozgen U, Aydogdu I, Soylu H (2000) Severe epistaxis in brucellosis-induced isolated thrombocytopenia: a report of two cases. Clin Lab Haematol 22(6):373–375PubMedCrossRef
Metadaten
Titel
Isolated Severe Immune Thrombocytopenia due to Acute Brucellosis
verfasst von
Ozlem Guzel Tunccan
Murat Dizbay
Esin Senol
Zeynep Aki
Kevser Ozdemir
Publikationsdatum
01.09.2014
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe Sonderheft 1/2014
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-012-0222-3

Weitere Artikel der Sonderheft 1/2014

Indian Journal of Hematology and Blood Transfusion 1/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.